# INTRAGO-Intraoperative Radiotherapy for Glioblastoma - a Phase I/II Study

> **NCT02104882** · PHASE1,PHASE2 · COMPLETED · sponsor: **Universitätsmedizin Mannheim** · enrollment: 12 (actual)

## Conditions studied

- Glioblastoma Multiforme

## Interventions

- **RADIATION:** Intraoperative Radiotherapy (Applicator Surface Dose: 20-40 Gy)

## Key facts

- **NCT ID:** NCT02104882
- **Lead sponsor:** Universitätsmedizin Mannheim
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2016-09
- **Final completion:** 2016-09
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2016-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02104882

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02104882, "INTRAGO-Intraoperative Radiotherapy for Glioblastoma - a Phase I/II Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02104882. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*